Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

NCT00026143 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

NIH

Sponsor class

Conditions

Recurrent Melanoma
Stage IV Melanoma

Interventions

BIOLOGICAL: recombinant interleukin-12
BIOLOGICAL: recombinant interferon alfa
OTHER: laboratory biomarker analysis

Sponsor

National Cancer Institute (NCI)